Extended Phase II Results for a Nurr 1 / DHDOH inhibitor
Hot off the press ...
just published and co-authored by Dr Wolf:
Safety and Dose-Response of Vidofludimus Calcium in Relapsing Multiple Sclerosis.
Extended Results of a Placebo-Controlled Phase 2 Trial
Robert J Fox, Heinz Wiendl, Christian Wolf, Nicola De Stefano, Johann Sellner, Viktoriia Gryb, Konrad Rejdak, Plamen S Bozhinov, Daniel Vitt, Hella Kohlhof, Jason Slizgi, Matej Ondrus, Valentina Sciacca, Andreas R Muehler; for the EMPhASIS investigators.
Neurol Neuroimmunol Neuroinflamm 2024;11:e200208. Full text: doi:10.1212/NXI.0000000000200208